Turkey Bioinformatics Market Analysis Report 2022 to 2030

Turkey Bioinformatics Market Analysis

$ 3999

Turkey's Bioinformatics market is projected to grow from $122.8 Mn in 2022 to $425.34 Mn by 2030, registering a CAGR of 16.80% during the forecast period of 2022-30. The main factors driving the growth would be the growing biotechnology industry, government support, and increasing demand for precision medicine. The market is segmented by technology and by application. Some of the major players include Erlab Technology (TUR), Iontek (TUR), Seven Bridges Genomics, Qiagen, and Bruker Corporation.

ID: IN10TRHS001 CATEGORY: Healthcare Services GEOGRAPHY: Turkey AUTHOR: Neha Davda

Buy Now

Turkey Bioinformatics Market Executive Summary

Turkey's Bioinformatics market is projected to grow from $122.8 Mn in 2022 to $425.34 Mn by 2030, registering a CAGR of 16.80% during the forecast period of 2022-30. In 2019, national healthcare spending in Turkey as a percentage of GDP was 4.34% achieving $396 per capita. In Turkey, health spending per person increased from 154 US dollars in 2001 to 571 US dollars in 2008, but between 2008 and 2019, it decreased by an average of 1.81% year.

Bioinformatics is the management and analysis of biological data using computer technology. It entails gathering, analyzing, and disseminating biological data. In order to determine the functions of genes and proteins, identify evolutionary relationships, and predict the three-dimensional forms of proteins, computer programs are used. The bioinformatics market in Turkey is still relatively small and developing compared to established markets like the US and Europe.

turkey bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The Turkey bioinformatics market is expected to be driven by factors such as the growing biotechnology industry, government support, and increasing demand for precision medicine. Moreover, Turkey's expanding patient population and use of electronic health records may result in more data being available for bioinformatics study and analysis, which could in turn drive the growth of bioinformatics in the country.

Market Restraints

The factors which are limiting the growth of the bioinformatics market in Turkey are a shortage of skilled professionals and a lack of infrastructure and resources for bioinformatics. Also, large patient data sets may not be readily available in Turkey for bioinformatics research and analysis, which would hinder the sector's expansion.

Competitive Landscape

Key Players

Erlab Technology (TUR)
Iontek (TUR)
Seven Bridges Genomics
Qiagen
Bruker Corporation

Notable Recent Deals

December 2021: Erlab announced the acquisition of Noroit, a french manufacturer of biological safety cabinets, laminar airflow enclosures, etc. With this acquisition, customers can expect ERLAB to introduce an unprecedented range of new filtration technologies, providing a holistic product offering spanning across multiple scientific disciplines like chemistry, biochemistry, healthcare, and environmental pollution. This acquisition signals the company's commitment to innovation, safety, and quality, which it will continue to uphold.

Healthcare Policies and Regulatory Landscape

The comprehensive healthcare system in Turkey is governed by a number of laws and rules. The Ministry of Health, which is in charge of the system's general management and administration, oversees the Turkish healthcare system. The government provides access to healthcare services for all citizens under the universal coverage principle that underpins the healthcare system. The public hospital system, primary care clinics, and specialty clinics form the backbone of the healthcare system. The healthcare services offered by private hospitals and clinics are likewise subject to government regulation.

The requirements for medical education and the procedures for healthcare provider accreditation are among the policies and guidelines that the Ministry of Health establishes for the healthcare system. The Ministry is also in charge of setting the rates for medicines, medical equipment, and other health-related goods. It is also in charge of paying for citizens' medical bills.

The Ministry of Health also controls how medical information is used and handled, including the security and privacy of patient data to be used for bioinformatics. The Ministry is also in charge of enforcing the Medical Devices and Pharmacy Act, which governs the licensing of pharmacies, the production of medications, and the registration, import, and distribution of medical devices.

Reimbursement Scenario

In Turkey, the Ministry of Health is largely responsible for providing healthcare services. The government also controls how healthcare services are reimbursed. In Turkey, the Social Security Institution (SSI) is primarily in charge of paying for medical treatments. Prescription medications, preventive services, inpatient and outpatient care, and a wide range of other services are all covered. Patients are asked to provide a small co-payment for some services; however, the SSI pays for the majority of the expenditures. Turkish citizens can also purchase private health insurance, which can pay for extra services not covered by the SSI.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.